RILYP Q1 2024 Earnings Negative EPS Amid Preferred Stock Challenges Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress BMRC Q1 2026 Earnings EPS Misses Estimates as Loan Portfolio Pressures Emerge ATO Q1 2026 Earnings EPS Beats Estimates Amidst Operational Discipline Webster Financial Q1 2026 Earnings EPS Tops Estimates Despite Market Softness GPRK Q1 2026 Earnings Solid EPS Performance Amid Limited Consensus Data